Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2026)

Akebia Therapeutics has reported Debt Ratio over the past 8 years, most recently at 0.13 for Q4 2025.

  • Quarterly Debt Ratio fell 26.93% to 0.13 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13 through Dec 2025, down 26.93% year-over-year, with the annual reading at 0.13 for FY2025, 26.93% down from the prior year.
  • Debt Ratio was 0.13 for Q4 2025 at Akebia Therapeutics, down from 0.13 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.19 in Q4 2022 and troughed at 0.13 in Q4 2025.
  • The 5-year median for Debt Ratio is 0.16 (2021), against an average of 0.16.
  • Year-over-year, Debt Ratio surged 59.11% in 2021 and then fell 29.34% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.18 in 2021, then grew by 0.71% to 0.19 in 2022, then dropped by 22.68% to 0.14 in 2023, then increased by 22.2% to 0.18 in 2024, then dropped by 26.93% to 0.13 in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Debt Ratio are 0.13 (Q4 2025), 0.13 (Q3 2025), and 0.14 (Q2 2025).